drug development

R&D

Supercharging clinical development with RWE – with Recursion...

Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.

News

FDA plans to phase out animal testing for antibodies

The FDA has said it intends to reduce or replace animal testing of some medicines, including monoclonal antibodies, with other methods.

R&D

Defining success for early-stage, small biotech trials

Small biotech companies encounter significant challenges in designing and implementing clinical development programmes.

R&D

Partner Content

6th Cytokine-Based Drug Development Summit 2025

With more cytokine-based drugs entering clinical trials and novel combination and masking technologies being used, there is a growing need for experts to discuss, understand, and build on t

Digital

Balancing innovation and efficiency in clinical trials: Is t...

Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes

R&D

Life Sciences Industry Report - Part 6

There are some 7,000 known rare diseases in the world, yet, multiple challenges and unmet needs remain when it comes to therapies for these diseases.